Diversification and Discipline Drive Gains for Model Shadow Stock Portfolio
The model portfolio outperforms in a weak month for small stocks. Plus, the quarterly review results in three changes.
John Bajkowski
Stock Evaluator: USANA Health Sciences, Inc. (USNA)
USANA Health Sciences, Inc. USNA
$13.63
-0.23
-1.66%
November 6, 2026 4:00:03 PM
EST
Volume: 292,321
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Staples | Personal Care Products |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Commentary & Analysis
Outperformance and 10 Changes for the Model Shadow Stock Portfolio
The model portfolio’s quarterly review results in five deletions and five additions.
John Bajkowski
3 Undervalued Personal Care Products Stocks for Wednesday, May 27
Discover the top 3 undervalued Personal Care Products stocks for Wednesday, May 27 based on AAII’s Stock Grades.Rosalio Madrigal
Why USANA Health Sciences, Inc.’s (USNA) Stock Is Up 5.81%
As of Wednesday, May 27, USANA Health Sciences, Inc.’s USNA share price has surged by 5.81%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why USANA Health Sciences, Inc.’s (USNA) Stock Is Down 5.91%
As of Monday, May 11, USANA Health Sciences, Inc.’s USNA share price has dipped by 5.91%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | USNA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $251.8 | $225.7 | 31% |
|
| Shares Out (Mil) | 18.5 | 20.7 | 29% |
|
| Institutional Ownership | 57.2% | 60.9% | 38% |
|
| Float (Mil) | 9.9 | 30.2 | 19% |
|
| Beta | 0.67 | 0.61 | 40% |
|
| Avg Daily Volume (000s) | 214 | 82 | 45% |
|
| Price Change (52-week) |
(33.2%) | 59.3% | 28% |
|
| Growth | USNA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (4.0%) | (0.1%) | 10% |
|
| Net Income (5yr) | (38.7%) | (8.6%) | 10% |
|
| EPS (5yr) | (37.0%) | (0.2%) | 6 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.5%) | (15.1%) | 37% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.120 | $0.550 | $1.770 | |
| Month Ago EPS | $0.110 | $0.760 | $1.770 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 2 | 0 | |
| Three Months Ago EPS | $0.110 | $0.760 | $1.770 | |
| Year/Year Chg | (110.3%) | (5.2%) | na | |
| Financials | USNA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $913 | $565 | 49% |
|
| Net Income (TTM) (Mil) | ($22) | $3 | 23% |
|
| EPS (TTM) | ($1.207) | $0.100 | 19% |
|
| Operating Cash Flow (TTM) (Mil) | $28 | $21 | 43% |
|
| Net Cash Flow (TTM) (Mil) | $17 | $1 | 61% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $33 | 0% |
|
| Enterprise Value (Q1) (Mil) | $278 | $352 | 29% |
|
| Valuation | USNA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.48 | 1.83 | 10% |
|
| P/E | na | 13.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.4 | na |
|
| Ratios | USNA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 77.3% | 62.6% | 87% |
|
| Net Margin | (2.3%) | 2.8% | 28% |
|
| ROA | (3.1%) | 2.3% | 32% |
|
| ROE | (4.2%) | 7.3% | 31% |
|
| Liabilities to Assets | 18.8% | 48.8% | 12% |
|
| F-Score | 4 | 4 | 33% |
|
USANA Health Sciences, Inc. did not pass any screens on 11/6/2026.
